NRx has applied to FDA for use of KETAFREE™ as a proprietary product name, which is subject to review. KETAFREE™ is the first preservative-free ketamine formulation that does not include potentially ...

Vestibular Migraine (VM) is a common clinical neurological disorder characterized by recurrent episodes of dizziness and headaches. It has a significant genetic predisposition and a high morbidity and ...

Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal Treatment-Resistant Bipolar Depression and Chronic Pain. - Designed to Help Address the Needs of Over 13 Million ...

Recent advances in understanding the brain’s dynamic functioning have been achieved through a wide range of experiments conducted across multiple levels of ...

Serenity Mental Health Centers offer personalized, in-person psychiatric services to help you overcome whatever is holding you back. Dr. David Gibson is here with more on their TMS treatments. TMS ...

Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the “Company”, “NRx”), a clinical-stage biopharmaceutical company and HOPE ...

The team behind the research are now preparing the first UK National Health Service trial to test whether nitrous oxide can ...

Over the past two decades, deep brain stimulation (DBS) has supplanted lesioning techniques for the treatment of movement disorders, and has been shown to be safe and efficacious. The primary ...

Background Knee MRI is increasingly used to inform clinical management. Features associated with osteoarthritis are often present in asymptomatic uninjured knees; however, the estimated prevalence ...